Zacks Investment Research
03 Aug 2026, 22:46 UTC · 1h ago
Medtronic (MDT) Laps the Stock Market: Here's Why
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
03 Aug 2026, 22:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Medtronic is currently assigned a Zacks Rank of #4 (Sell). — A 'Sell' rating from a quantitative model with a cited historical track record suggests a negative outlook for the stock's near-term performance.
-0.60Medtronic is forecasted to report an EPS of $1.39 and revenue of $9.48 billion for the upcoming quarter, representing growth of approximately 10% year-over-year. — Double-digit projected growth in both earnings and revenue is a positive fundamental signal for the company's trajectory.
+0.40Medtronic's Forward P/E ratio of 14.37 is a discount compared to its industry average of 19.53. — Trading at a discount to industry peers often suggests a more attractive valuation for value-oriented investors.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The stock outperformed the S&P 500 and has positive forecasted earnings growth, although it currently holds a Zacks Rank of #4 (Sell).
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
